NASDAQ:CBPO
Delisted
China Biologic Products Stock News
$119.99
+0 (+0%)
At Close: May 27, 2022
AlphaCrest Capital Management LLC Sells 8,600 Shares of China Biologic Products Holdings Inc (NASDAQ:CBPO)
08:14am, Wednesday, 18'th Mar 2020
AlphaCrest Capital Management LLC cut its holdings in shares of China Biologic Products Holdings Inc (NASDAQ:CBPO) by 64.2% during the fourth quarter, according to its most recent 13F filing with the
ProShare Advisors LLC Sells 2,027 Shares of China Biologic Products Holdings Inc (NASDAQ:CBPO)
09:38am, Tuesday, 17'th Mar 2020
ProShare Advisors LLC lowered its holdings in shares of China Biologic Products Holdings Inc (NASDAQ:CBPO) by 19.6% during the 4th quarter, according to the company in its most recent filing with the
Edited Transcript of CBPO.OQ earnings conference call or presentation 13-Mar-20 11:30am GMT
08:45pm, Friday, 13'th Mar 2020
Q4 2019 China Biologic Products Holdings Inc Earnings Call
China Biologic Products Inc (CBPO) Q4 2019 Earnings Call Transcript
06:30pm, Friday, 13'th Mar 2020
CBPO earnings call for the period ending December 31, 2019.
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q4 2019 Results - Earnings Call Transcript
03:07pm, Friday, 13'th Mar 2020
China Biologic Products Holdings, Inc. (NASDAQ:CBPO) Q4 2019 Earnings Conference Call March 13, 2020, 07:30 ET Company Participants Samuel Martin - IR Joseph Ch
China Biologic Products: 4Q Earnings Snapshot
09:34pm, Thursday, 12'th Mar 2020
BEIJING (AP) _ China Biologic Products Inc. (CBPO) on Thursday reported fourth-quarter earnings of $12.5 million.
The Beijing-based company said it had profit of 32 cents per share. Earnings, adjusted
BRIEF-China Biologic Reports Financial Results For The Fourth Quarter And Fiscal Year 2019
09:02pm, Thursday, 12'th Mar 2020
China Biologic Products Holdings Inc :
China Biologic Products Q4 EPS $0.53 Down From $0.76 YoY, Sales $102.2M Miss $125.3M Estimate
09:01pm, Thursday, 12'th Mar 2020China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019
09:00pm, Thursday, 12'th Mar 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial resu
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
Buyout group nears completion of China Biologic deal | PitchBook
09:08am, Thursday, 12'th Mar 2020
A group including Centurium Capital-backed Beachhead Holdings is in the final stage of negotiations to take China Biologic Products private for $120 per share, according to Bloomberg. The offer,...
Titan Pharmaceuticals (NASDAQ:TTNP) & China Biologic Products (NASDAQ:CBPO) Financial Comparison
06:48am, Thursday, 12'th Mar 2020
Titan Pharmaceuticals (NASDAQ:TTNP) and China Biologic Products (NASDAQ:CBPO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength o
Barclays PLC Has $947,000 Position in China Biologic Products Holdings Inc (NASDAQ:CBPO)
09:58am, Wednesday, 11'th Mar 2020
Barclays PLC lowered its stake in shares of China Biologic Products Holdings Inc (NASDAQ:CBPO) by 7.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and E
China Biologic, Suitor Are in Advanced Talks on Take-Private
02:41pm, Tuesday, 10'th Mar 2020
(Bloomberg) -- A Chinese buyout group is in advanced talks to take U.S.-listed China Biologic Products Holdings Inc. private, according to people with knowledge of the matter.Negotiations have entered
China Biologic, Suitor Arein Advanced Talks on Take-Private
08:09am, Tuesday, 10'th Mar 2020
A Chinese buyout group is in advanced talks to take New York-listed China Biologic Products Holdings Inc. private, according to people with knowledge of the matter.
